| abstract |
The present invention provides a C, O-spiroaryl glycoside compound and its production and use, specifically, a compound represented by the following formula (I). Here, the group of each group is as described in the specification. The above compounds can be used as SGLT2 inhibitors in the manufacture of pharmaceutical compositions for treating diseases such as diabetes, atherosclerosis and obesity. |